Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

Urology

Volumn 52, Issue 3, 1998, Pages 398-402

  Landman, Jaime ^a   Chang, Yongli ^a   Kavaler, Elizabeth ^a   Droller, Michael J ^a   Liu, Brian C S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TUMOR ANTIGEN;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENETIC ANALYSIS; HEMATURIA; HUMAN; MALE; MARKER GENE; PRIORITY JOURNAL;

AGED; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0032169301     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00219-2     Document Type: Article

References (24)

1. 1. Herr HW: Bladder cancer: natural history and implications for urothelial cancer prevention. J Cell Biol Chem 16: 112-119, 1992.
2. 2. Loening S, Narayana A, Yoder L, et al: Factors influencing the recurrence rate of bladder cancer. J Urol 123: 29-31, 1980.
3. 3. Rabb SS, Lenel J, and Cohen MB: Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 74: 1621-1626, 1994.
4. 4. Badalament RA, Hermansen DK, Kimmel M, et al: The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 60: 1423-1427, 1987.
5. 5. Berezney R, and Coffey DS: Identification of a nuclear protein matrix. Biochem Biophys Res Commun 60: 1410-1417, 1974.
6. 6. Pardoll DM, Vogelstein B, and Coffey DS: A fixed site of DNA replication in eukaryotic cells. Cell 19: 527-536, 1980.
7. 7. Zeitlin S, Parent A, Silverstein S, et al: Pre-mRNA splicing and the nuclear matrix. Mol Cell Biol 7: 111-120, 1987.
8. 8. Gordon JN, Shu WP, Schlussel RN, et al: Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells. Cancer Res 53: 4971-4977, 1993.
9. 9. Nakayasu H, and Berezney R: Mapping replicational sites in the eukaryotic nucleus. J Cell Biol 108: 1-11, 1989.
10. 10. Yang CH, Lambie EJ, and Snyder M: NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol 116: 1303-1317, 1992.
11. 11. Compton DA, and Cleveland DW: NuMA is required for the proper completion of mitosis. J Cell Biol 120: 947-957, 1993.
12. 12. Keesee SK, Briggman JV, Thill G, et al: Utilization of nuclear matrix proteins for cancer diagnosis. CRC Crit Rev Eukaryotic Gene Expr 6: 189-214, 1996.
13. 13. Carpinito GA, Stadler WM, Briggman JV, et al: Urinary nuclear matrix protein as marker for transitional cell carcinoma of urinary tract. J Urol 156: 1280-1285, 1996.
14. 14. Soloway MS, Briggman JV, Carpinito GA, et al: Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156: 363-367, 1996.
15. 15. Liotta LA, Rao CN, and Wewer UM: Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037-1057, 1986.
16. 16. Sarosdy MF, deVere White RW, Soloway MS, et al: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 379-384, 1995.
17. 17. D'Hallewin M-A, and Baert L: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475-476, 1996.
18. 18. Blackburn EH: Telomeres: no end in sight. Cell 77: 621-623, 1994.
19. 19. Harley CB, Futcher AB, and Greider CW: Telomeres shorten during ageing of human fibroblast. Nature 345: 458-460, 1990.
20. 20. Blackburn EH: Telomerases. Annu Rev Biochem 61: 113-129, 1992.
21. 21. Kavaler E, Landman J, Chang Y, et al: Detection of human bladder cancer cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 82: 708-714, 1998.
22. 22. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
23. 23. Bodnar A, Kim NW, Effros RB, et al: Mechanism of telomerase induction during T cell activation. Exp Cell Res 228: 58-64, 1996.
24. 24. Bodnar AG, Ouellette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.